Affordable Access

deepdyve-link
Publisher Website

Correction to: Targeted Anti-IL-5 Therapies and Future Therapeutics for Hypereosinophilic Syndrome and Rare Eosinophilic Conditions.

Authors
  • Harish, Aasha1
  • Schwartz, Stanley A2
  • 1 Division of Allergy and Immunology, Department of Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, 1020 Youngs Road, Williamsville, NY, 14221, USA. [email protected]
  • 2 Division of Allergy and Immunology, Department of Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, 1020 Youngs Road, Williamsville, NY, 14221, USA.
Type
Published Article
Journal
Clinical Reviews in Allergy & Immunology
Publisher
Springer-Verlag
Publication Date
Oct 01, 2020
Volume
59
Issue
2
Pages
273–273
Identifiers
DOI: 10.1007/s12016-020-08781-x
PMID: 32189231
Source
Medline
Language
English
License
Unknown

Abstract

The original version of this article unfortunately contained a mistake in the fifth paragraph of the "Conclusion" section.

Report this publication

Statistics

Seen <100 times